247 related articles for article (PubMed ID: 18286567)
1. IRAK-4 kinase activity is required for IRAK-4-dependent innate and adaptive immune responses.
Lye E; Dhanji S; Calzascia T; Elford AR; Ohashi PS
Eur J Immunol; 2008 Mar; 38(3):870-6. PubMed ID: 18286567
[TBL] [Abstract][Full Text] [Related]
2. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4.
Suzuki N; Suzuki S; Duncan GS; Millar DG; Wada T; Mirtsos C; Takada H; Wakeham A; Itie A; Li S; Penninger JM; Wesche H; Ohashi PS; Mak TW; Yeh WC
Nature; 2002 Apr; 416(6882):750-6. PubMed ID: 11923871
[TBL] [Abstract][Full Text] [Related]
3. Differential role of IL-2R signaling for CD8+ T cell responses in acute and chronic viral infections.
Bachmann MF; Wolint P; Walton S; Schwarz K; Oxenius A
Eur J Immunol; 2007 Jun; 37(6):1502-12. PubMed ID: 17492805
[TBL] [Abstract][Full Text] [Related]
4. The critical role of kinase activity of interleukin-1 receptor-associated kinase 4 in animal models of joint inflammation.
Koziczak-Holbro M; Littlewood-Evans A; Pöllinger B; Kovarik J; Dawson J; Zenke G; Burkhart C; Müller M; Gram H
Arthritis Rheum; 2009 Jun; 60(6):1661-71. PubMed ID: 19479877
[TBL] [Abstract][Full Text] [Related]
5. IRAK-4 kinase activity-dependent and -independent regulation of lipopolysaccharide-inducible genes.
Koziczak-Holbro M; Glück A; Tschopp C; Mathison JC; Gram H
Eur J Immunol; 2008 Mar; 38(3):788-96. PubMed ID: 18266302
[TBL] [Abstract][Full Text] [Related]
6. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
[TBL] [Abstract][Full Text] [Related]
7. Impaired anti-viral T cell responses due to expression of the Ly49A inhibitory receptor.
Zajac AJ; Vance RE; Held W; Sourdive DJ; Altman JD; Raulet DH; Ahmed R
J Immunol; 1999 Nov; 163(10):5526-34. PubMed ID: 10553080
[TBL] [Abstract][Full Text] [Related]
8. IL-12 is not required for induction of type 1 cytokine responses in viral infections.
Oxenius A; Karrer U; Zinkernagel RM; Hengartner H
J Immunol; 1999 Jan; 162(2):965-73. PubMed ID: 9916721
[TBL] [Abstract][Full Text] [Related]
9. CD40 ligand is pivotal to efficient control of virus replication in mice infected with lymphocytic choriomeningitis virus.
Thomsen AR; Nansen A; Christensen JP; Andreasen SO; Marker O
J Immunol; 1998 Nov; 161(9):4583-90. PubMed ID: 9794385
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor cross-hyporesponsiveness is functional in interleukin-1-receptor-associated kinase-1 (IRAK-1)-deficient macrophages: differential role played by IRAK-1 in regulation of tumour necrosis factor and interleukin-10 production.
Berglund M; Thomas JA; Hörnquist EH; Hultgren OH
Scand J Immunol; 2008 May; 67(5):473-9. PubMed ID: 18405325
[TBL] [Abstract][Full Text] [Related]
11. Solving the IRAK-4 enigma: application of kinase-dead knock-in mice.
Koziczak-Holbro M; Joyce C; Glück A; Kinzel B; Müller M; Gram H
Ernst Schering Found Symp Proc; 2007; (3):63-82. PubMed ID: 18510099
[TBL] [Abstract][Full Text] [Related]
12. 4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses.
Tan JT; Whitmire JK; Ahmed R; Pearson TC; Larsen CP
J Immunol; 1999 Nov; 163(9):4859-68. PubMed ID: 10528187
[TBL] [Abstract][Full Text] [Related]
13. Hyperthermia differentially regulates TLR4 and TLR2-mediated innate immune response.
Zhao W; An H; Zhou J; Xu H; Yu Y; Cao X
Immunol Lett; 2007 Feb; 108(2):137-42. PubMed ID: 17196259
[TBL] [Abstract][Full Text] [Related]
14. CD40-CD40 ligand costimulation is required for generating antiviral CD4 T cell responses but is dispensable for CD8 T cell responses.
Whitmire JK; Flavell RA; Grewal IS; Larsen CP; Pearson TC; Ahmed R
J Immunol; 1999 Sep; 163(6):3194-201. PubMed ID: 10477587
[TBL] [Abstract][Full Text] [Related]
15. Effects of IL-12 on the response and susceptibility to experimental viral infections.
Orange JS; Wolf SF; Biron CA
J Immunol; 1994 Feb; 152(3):1253-64. PubMed ID: 7905500
[TBL] [Abstract][Full Text] [Related]
16. Tumor-infiltrating lymphocytes exhibiting high ex vivo cytolytic activity fail to prevent murine melanoma tumor growth in vivo.
Prévost-Blondel A; Zimmermann C; Stemmer C; Kulmburg P; Rosenthal FM; Pircher H
J Immunol; 1998 Sep; 161(5):2187-94. PubMed ID: 9725210
[TBL] [Abstract][Full Text] [Related]
17. A critical role for the innate immune signaling molecule IRAK-4 in T cell activation.
Suzuki N; Suzuki S; Millar DG; Unno M; Hara H; Calzascia T; Yamasaki S; Yokosuka T; Chen NJ; Elford AR; Suzuki J; Takeuchi A; Mirtsos C; Bouchard D; Ohashi PS; Yeh WC; Saito T
Science; 2006 Mar; 311(5769):1927-32. PubMed ID: 16574867
[TBL] [Abstract][Full Text] [Related]
18. Altered kinetics of CD4+ T cell proliferation and interferon-gamma production in the absence of CD8+ T lymphocytes in virus-infected beta2-microglobulin-deficient mice.
Vikingsson A; Pederson K; Muller D
Cell Immunol; 1996 Nov; 173(2):261-8. PubMed ID: 8912885
[TBL] [Abstract][Full Text] [Related]
19. Plasmid DNA vaccines are effective in the absence of IFNgamma.
Hassett DE; Zhang J; Whitton JL
Virology; 1999 Oct; 263(1):175-83. PubMed ID: 10544092
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1 receptor-associated kinase-M suppresses systemic lupus erythematosus.
Lech M; Kantner C; Kulkarni OP; Ryu M; Vlasova E; Heesemann J; Anz D; Endres S; Kobayashi KS; Flavell RA; Martin J; Anders HJ
Ann Rheum Dis; 2011 Dec; 70(12):2207-17. PubMed ID: 21875872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
